Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 11 No. 2 (2005)

Vol. 11 No. 2 (2005)

Published: 2005-01-01

Editorial

  • Editorial: Biomarkers – The kiss of death

    Todd Krueger
    • PDF

Article

  • Australian biotech companies: Navigating the maze

    Timothy F Herpin, Helen Karuso, James E Foley
    • PDF
  • New Technology Transfer Block Exemption and Guidelines: A challenge for biotechnology

    Tim Gunn
    • PDF
  • Survival strategies for start-ups

    Dina Chaya
    • PDF
  • International mega-trends and growth prospects of the Finnish biotechnology industry: Recent economic research and policy implications

    Raine Hermans, Martti Kulvik, Pekka Ylä-Anttila
    • PDF
  • Growth of Indian biotech companies, in the context of the international biotechnology industry

    Utkarsh Palnitkar
    • PDF
  • Determining the value of drug development candidates and technology platforms

    Kerstin M Bode-Greuel, Joachim M Greuel
    • PDF
  • Key financial trends that shape biotech business growth

    Alex Pavlou, Mark Belsey
    • PDF

Legal and Regulatory Updates

  • Legal and regulatory update

    John Wilkinson
    • PDF
  • Financial accounts reports

    Colin Aaronson
    • PDF

Book Review

  • Book Review: The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution

    Derek Burke
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust